219 related articles for article (PubMed ID: 14655151)
21. Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors.
Folpe AL; Gown AM; Lamps LW; Garcia R; Dail DH; Zarbo RJ; Schmidt RA
Mod Pathol; 1999 Jan; 12(1):5-8. PubMed ID: 9950155
[TBL] [Abstract][Full Text] [Related]
22. The frequency of neuroendocrine cell hyperplasia in patients with pulmonary neuroendocrine tumours and non-neuroendocrine cell carcinomas.
Rizvi SM; Goodwill J; Lim E; Yap YK; Wells AU; Hansell DM; Davis P; Selim AG; Goldstraw P; Nicholson AG
Histopathology; 2009 Sep; 55(3):332-7. PubMed ID: 19723148
[TBL] [Abstract][Full Text] [Related]
23. Expression of neuroendocrine and epithelial markers in an adherent subline derived from a classic small cell lung cancer cell line.
Walker C; Wright-Perkins S
Oncol Res; 1992; 4(10):419-29. PubMed ID: 1337994
[TBL] [Abstract][Full Text] [Related]
24. Expression of TdT in Merkel cell carcinoma and small cell lung carcinoma.
Sidiropoulos M; Hanna W; Raphael SJ; Ghorab Z
Am J Clin Pathol; 2011 Jun; 135(6):831-8. PubMed ID: 21571955
[TBL] [Abstract][Full Text] [Related]
25. Detection of cytoskeletal proteins in small cell lung carcinoma.
Hlozánková M; Lukás Z; Viklický V
Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():47-9. PubMed ID: 10707834
[TBL] [Abstract][Full Text] [Related]
26. High-grade neuroendocrine carcinoma of the lung: comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma.
Sun L; Sakurai S; Sano T; Hironaka M; Kawashima O; Nakajima T
Pathol Int; 2009 Aug; 59(8):522-9. PubMed ID: 19627535
[TBL] [Abstract][Full Text] [Related]
27. Nuclear overexpression of the E2F3 transcription factor in human lung cancer.
Cooper CS; Nicholson AG; Foster C; Dodson A; Edwards S; Fletcher A; Roe T; Clark J; Joshi A; Norman A; Feber A; Lin D; Gao Y; Shipley J; Cheng SJ
Lung Cancer; 2006 Nov; 54(2):155-62. PubMed ID: 16938365
[TBL] [Abstract][Full Text] [Related]
28. Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays.
Wikman H; Seppänen JK; Sarhadi VK; Kettunen E; Salmenkivi K; Kuosma E; Vainio-Siukola K; Nagy B; Karjalainen A; Sioris T; Salo J; Hollmén J; Knuutila S; Anttila S
J Pathol; 2004 May; 203(1):584-93. PubMed ID: 15095482
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of MIB-1 in neuroendocrine tumours of the lung.
Böhm J; Koch S; Gais P; Jütting U; Präuer HW; Höfler H
J Pathol; 1996 Apr; 178(4):402-9. PubMed ID: 8691318
[TBL] [Abstract][Full Text] [Related]
30. Modulation of neuroendocrine differentiation in prostate cancer by interleukin-1 and -2.
Diaz M; Abdul M; Hoosein N
Prostate Suppl; 1998; 8():32-6. PubMed ID: 9690661
[TBL] [Abstract][Full Text] [Related]
31. Heterogeneity of so-called neuroendocrine lung tumors.
Yesner R
Exp Mol Pathol; 2001 Jun; 70(3):179-82. PubMed ID: 11417996
[TBL] [Abstract][Full Text] [Related]
32. [Small cell carcinoma and carcinoids of the lung: morphology of apoptosis and expression of biomolecular markers of tumor growth].
Pal'tsev MA; Demura SA; Kogan EA; Jack G; Zende B
Arkh Patol; 2000; 62(5):11-7. PubMed ID: 11076293
[TBL] [Abstract][Full Text] [Related]
33. Differentiation markers as an aid in the histological diagnosis of small-cell carcinoma of the lung: synopsis of intermediate filament protein and synaptophysin expression.
Leube RE; Wiedenmann B; Franke WW
Klin Wochenschr; 1988; 66 Suppl 11():80-6. PubMed ID: 2846953
[TBL] [Abstract][Full Text] [Related]
34. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
[TBL] [Abstract][Full Text] [Related]
35. Paucity of beta 2-microglobulin expression on small cell lung cancer, bronchial carcinoids and certain other neuroendocrine tumors.
Funa K; Gazdar AF; Minna JD; Linnoila RI
Lab Invest; 1986 Aug; 55(2):186-93. PubMed ID: 3525983
[TBL] [Abstract][Full Text] [Related]
36. [Detection of neuroendocrine differentiation in NSCLC and its clinical significance].
Ouyang N; Chen G; Ding J
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Feb; 24(2):90-2. PubMed ID: 11802946
[TBL] [Abstract][Full Text] [Related]
37. Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas.
Linnoila RI; Mulshine JL; Steinberg SM; Funa K; Matthews MJ; Cotelingam JD; Gazdar AF
Am J Clin Pathol; 1988 Dec; 90(6):641-52. PubMed ID: 2848408
[TBL] [Abstract][Full Text] [Related]
38. [Bronchial carcinoid and small cell lung cancer--neuroendocrine tumors. Immunohistochemical studies].
Maryniak R; Nasierowska A
Pneumonol Pol; 1989; 57(10-12):489-95. PubMed ID: 2561612
[TBL] [Abstract][Full Text] [Related]
39. Cystic fibrosis transmembrane conductance regulator modulates neurosecretory function in pulmonary neuroendocrine cell-related tumor cell line models.
Pan J; Bear C; Farragher S; Cutz E; Yeger H
Am J Respir Cell Mol Biol; 2002 Nov; 27(5):553-60. PubMed ID: 12397014
[TBL] [Abstract][Full Text] [Related]
40. Differential expression of telomerase activity in neuroendocrine lung tumours: correlation with gene product immunophenotyping.
Zaffaroni N; De Polo D; Villa R; Della Porta C; Collini P; Fabbri A; Pilotti S; Daidone MG
J Pathol; 2003 Sep; 201(1):127-33. PubMed ID: 12950025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
